Literature DB >> 36261

Kinetics of theophylline; variability and effect of arterial pH in chronic obstructive lung disease.

R K Resar, P D Walson, W L Fritz, D F Perry, R A Barbee.   

Abstract

The pharmacokinetic behavior of theophylline was determined in 12 patients during an acute exacerbation of their chronic obstructive pulmonary disease. A 5.6 mg/kg loading dose of aminophylilne was administered, followed three hours later by a 0.9 mg/kg/hr continuous infusion. The loading dose increased the serum theophylline level an average of only 5.77 microgram/ml. After the loading dose, only five patients had levels greater than 10 microgram/ml. Mean initial drug clearance was 0.77 L/kg/hr, half-life 9.1 hr, and apparent volume of drug distribution .887 L/kg. Wide inter- and intrapatient pharmacokinetic variability was observed. The variability of drug distribution was inversely correlated with the arterial pH. These patients with chronic obstructive pulmonary disease appeared to require more theophylline when acidemic than when alkalemic to achieve similar serum theophylline concentrations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36261     DOI: 10.1378/chest.76.1.11

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Control of asthma.

Authors:  J Dolovich; F E Hargreave; W M Wilson; J Greenbaum; A C Powles; M T Newhouse
Journal:  Can Med Assoc J       Date:  1982-03-15       Impact factor: 8.262

Review 2.  Status asthmaticus in adults.

Authors:  H Don
Journal:  Clin Rev Allergy       Date:  1985-02

3.  Monitoring aminophylline therapy using Jusko's dosage guidelines.

Authors:  E P Calandre; A J Perez de la Cruz; A M Morales; N P Alférez; E Moreno; G V Mata
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

Review 4.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

5.  Cardiovascular effects of theophylline. Partial attenuation by beta-blockade.

Authors:  K A Conrad; E H Prosnitz
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 6.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

7.  Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.

Authors:  Y Horai; T Ishizaki; T Sasaki; M Watanabe; J Kabe
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 8.  Hypoxia, arterial pH and theophylline disposition.

Authors:  M Richer; Y W Lam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

Review 9.  The Evidence for Intravenous Theophylline Levels between 10-20mg/L in Children Suffering an Acute Exacerbation of Asthma: A Systematic Review.

Authors:  Lewis Cooney; Daniel Hawcutt; Ian Sinha
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.